STRATA Skin Sciences, Inc. (SSKN): Nasdaq/NYSE listing notice — STRATA Skin Sciences regains compliance with Nasdaq minimum bid price rule

STRATA Skin Sciences, Inc.

Received Nasdaq notice on Feb 27, 2023 confirming compliance with Rule 5550(a)(2).
Company will continue trading on Nasdaq; delisting risk removed.
CEO Robert Moccia expressed satisfaction with regaining full listing compliance.
No financial impact or other material changes reported.

item 3.01 item 7.01 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

STRATA Skin Sciences, Inc. received a nasdaq compliance regained notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 27, 2023 STRATA Skin Sciences, Inc. (the “Company”) received notice from The NASDAQ Stock Market (“Nasdaq”) that, STRATA has regained compliance with the Nasdaq listing requirements as required by Rule 5550(a)(2) r egarding the Company’s minimum bid price , and the Company will continue to trade on Nasdaq.

View on SEC.gov

Browse all listing & compliance notices →

STRATA Skin Sciences, Inc. filing history →

Source: SEC EDGAR

accession 0001051514-23-000011

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.